Related Articles
The effect of proton pump inhibitors and vonoprazan on the development of ‘gastric mucosal redness’
Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors
Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
Differences in estrogen and progesterone receptor expression in endometrial polyps and atrophic endometrium of postmenopausal women with and without exposure to tamoxifen
Long‑term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor‑resistant gastroesophageal reflux disease